Divis Laboratories Ltd


BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 
Market Cap: [Rs.Cr.] 13,204 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Board Meet

20-May-13 
Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 20, 2013, inter alia, to consider and approve the audited financial results for the year ended March 31, 2013 and to recommend Dividend on Equity Shares for the year ended March 31, 2013, if any. 
02-Feb-13 
Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 02, 2013, inter alia, to consider and approve, the un-audited financial results for the third quarter ended December 31, 2012 (Q3). 
03-Nov-12 
Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 03, 2012, inter alia, to consider and approve, the un-audited financial results for the second quarter ended September 30, 2012 (Q2). Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2012, has appointed Sri. Ranga Rao Ravipati as Additional Director (Independent and Non-Executive) on the Board of the Company w.e.f. November 03, 2012. Further the Company has informed that, Sri. G. Venkata Rao, Independent Director of the Company has resigned from the Board due to personal reasons and other preoccupations. The Board has accepted his resignation and appreciated his contribution to the Company. (As per BSE Announcement Dated on 03.11.2012)  
04-Aug-12 
Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 04, 2012, inter alia, to consider and approve, the un-audited financial results for the first quarter ended June 30, 2012 (Q1). 
12-May-12 
Divis Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 12, 2012, inter-alia, to consider and approve the audited financial results for the year ended March 31, 2012 and to recommend Dividend on Equity Shares for the year ended March 31, 2012, if any. Divis Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2012, inter alia, has recommended a dividend of 650% i.e. Rs. 13/- per equity share of Rs. 2/- face value for the year ended March 31, 2012. (As Per BSE Announcement Website Dated on 12/05/2012) 

AGM

06-Aug-12
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2012 to August 03, 2012 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on August 06, 2012. The dividend, when declared at the Annual General Meeting, will be credited / dispatched on August 20, 2012. Divis Laboratories Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company will be held on August 06, 2012. (As Per BSE Announcement Website Dated on 18/07/2012) Divis Laboratories Ltd has informed BSE that the 22nd Annual General Meeting (AGM) of the Company held on August 06, 2012. (As Per BSE Announcement Dated on 06.08.2012) Divi'S Laboratories Limited has informed the Exchange regarding details of Voting Results of Annual General Meeting of the Company held on August 06,2012 pursuant to clause 35A of Listing Agreement. (As Per Nse Bulletin Dated on 07.08.2012) 
08-Aug-11
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 18, 2011 to June 24, 2011 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on August 08, 2011. Further the Company has informed that Board of Directors at its meeting held on May 20, 2011 has recommended a dividend of 500% i.e. Rs. 10/- per equity share of Rs. 2/- face value for the year ended March 31, 2011 and the dividend, when declared at the Annual General Meeting, will be credited / dispatched between August 18, 2011 and August 20, 2011. Divis Laboratories Ltd has informed BSE that the members at the 21st Annual General Meeting (AGM) of the Company held on August 08, 2011, inter alia, have passed the following: 1. Adopted the audited accounts for the year ended March 31, 2011. 2. Approval for payment of dividend at Rs. 10/- for each equity share. 3. Re-appointment of Mr. G. Venkata Rao, as Director liable to retire by rotation. 4. Re-appointment of Dr. G. Suresh Kumar, as Director liable to retire by rotation. 5. Re-appointment of Mr. Madhusudana Rao Divi, as Director liable to retire by rotation. 6. Re-appointment of M/s. P. V. R. K. Nageswara Rao & Co., Chartered Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM. (As Per BSE Announcement Website dated on 08.08.2011)  
13-Aug-10
Divis Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 06, 2010 to July 10, 2010 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on August 14, 2010. With reference to the earlier announcement dated June 23, 2010 regarding Book Closure for Dividend & Annual General Meeting (AGM), Divis Laboratories Ltd has now informed BSE that the revised date of Annual General Meeting (AGM) is 'August 13, 2010' and not on 'August 14, 2010' as previously announced by the Company. (As Per BSE Announcement Dated on 23.06.2010) Divis Laboratories Ltd has informed BSE that the members at the 20th Annual General Meeting (AGM) of the Company held on August 13, 2010, inter alia, have accorded to the following: 1. Adopted the audited accounts for the year ended March 31, 2010. 2. Approval for payment of dividend at Rs. 6/- for each equity share. 3. Re-appointment of Dr. K Satyanarayana, Prof. C Ayyanna & Dr. P Gundu Rao as Directors liable to retire by rotation. 4. Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Chartered Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM. 5. Re-appointment of Dr. P Gundu Rao, as Director (R&D) of the Company and fixation of his remuneration. (As Per BSE Announcement Dated on 13.08.2010) 
17-Aug-09
AGM 17/08/2009 Divis Laboratories Ltd has informed BSE that the members at the 19th Annual General Meeting (AGM) of the Company held on August 17, 2009, inter alia, have passed the following resolutions: 1. Adopted the audited accounts for the year ended March 31, 2009. 2. Approval for payment of dividend at Rs 6 for each equity share. 3. Re-appointment of Mr. S Vasudev, Dr. G Suresh Kumar & Mr. Kiran S Divi, as Directors, liable to retire by rotation. 4. Re-appointment of M/s. P.V.R.K. Nageswara Rao & Co., Chartered Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM. (As Per BSE Announcement Dated on 17/08/2009) 
16-Aug-08
Divis Laboratories Ltd has informed BSE that an Annual General Meeting (AGM) of the Company will be held on August 16, 2008. Divis Laboratories Ltd has informed BSE that the members at the 18th Annual General Meeting (AGM) of the Company held on August 16, 2008, inter alia, have passed the following resolutions: 1. Adopted the audited accounts for the year ended March 31, 2008. 2. Approval for payment of dividend at Rs 4 for each equity share. 3. Re-appointment of Mr. G Venkata Rao, Prof. C Ayyanna & Mr. Madhusudana Rao Divi, as Directors liable to retire by rotation. 4. Re-appointment of M/s. P V R K Nageswara Rao & Co., Chartered Accountants, as Statutory Auditors of the Company to hold office till the conclusion of next AGM. 5. Revision of remuneration of Mr. Kiran S Divi, Director (Business Development). (As per BSE Announcement Website dated on 18/08/2008) 

EGM

16-May-06
Divi'S Laboratories Limited has informed the Exchange that the company has received letter of approval from Ministry of Commerce, Government of India, for setting up and development of a sector specific Special Economic Zone for pharmaceutical ingredients at Chippada, Bheemunipatnam. The details of land have also been notified in the Gezetee of India, Extraordinary on May 16, 2006. 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 34,401.90 27.29 7.10 21.23 23.4 22.7 0.30
Divi's Lab. 13,203.98 21.59 5.17 13.41 27.3 34.1 0.02
Jubilant Life 2,404.63 30.56 1.29 21.18 3.1 6.4 1.43
Shilpa Medicare 737.45 14.73 2.52 9.34 16.3 18.0 0.19
Hikal 676.83 26.53 1.97 5.65 22.4 18.2 1.53
Elder Pharma 578.92 6.29 0.75 6.59 12.9 13.0 1.25
Dishman Pharma. 566.51 11.70 0.84 5.44 6.8 10.2 0.80
Vinati Organics 554.45 8.08 2.30 5.63 33.2 31.3 0.75
Shasun Pharma. 447.42 16.23 1.65 7.48 14.0 8.9 1.05
Orchid Chemicals 433.27 0.00 0.47 7.67 9.7 8.3 1.75
Nectar Lifesci. 374.36 4.37 0.43 6.25 9.7 11.2 1.22
Sequent Scien. 341.37 0.00 2.24 7.62 -3.9 5.9 1.58
Suven Life Scie. 292.58 9.49 1.89 10.21 11.3 9.1 0.64
Granules India 273.97 9.08 1.01 4.12 11.7 15.2 0.57
Aarti Drugs 264.24 5.80 1.27 4.78 13.5 13.7 1.48

Futures & Options Quote

 
Expiry Date
999.30 9.75  [1.0]%
Instrument: FUTSTK
Expiry Date: 30 May 2013
Open Price: 1,010.15
Average Price: 998.70
No. of Contracts Traded: 340,500
Open Interest: 530,000
Underlying: DIVISLAB
Market Lot: 250
Previous Close: 999.30
Day’s High | Low: 1,019.90 | 986.40
Turnover (Cr.): 34.01
Open Int. Change: -5,500.00 ( [1.0]% )
View detailed F& O quotes >>

Key Information

Key Executives:

Murali K Divi , Chairman & Managing Director  

N V Ramana , Executive Director  

Madhusudana Rao Divi , Director (Projects)  

Kiran S Divi , President & Director  


Company Head Office / Quarters:
7-1-77/E/1/303 Divi Towers,
Dharam Karan Road Ameerpet,
Hyderabad,
Andhra Pradesh-500016
Phone : 91-40-23786300
Fax : 91-40-23786460
E-mail : mail@divislaboratories.com
Web : http://www.divislaboratories.com
Registrars:
Karvy Computershare Pvt Ltd
Plot No 17-24
Vittal Rao Nagar
Madhapur
Hyderabad-500081

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Closing : Just Dial
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Japan Buying Foreign Bonds (Yen)
Results
list Larsen & Toubro | Zee Entertainmen | Thermax